Overview

A Study to Investigate the Impact of Multiple Doses of Itraconazole on AZD5004 in Healthy Participants and Multiple Doses of AZD5004 on Combined Oral Ethinyl Oestradiol and Levonorgestrel in Healthy Female Participants

Status:
RECRUITING

Trial end date:
2026-03-25

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the impact of multiple doses of itraconazole on the pharmacokinetics (PK) of AZD5004 in healthy participants (Part A), and to assess the impact of multiple doses of AZD5004 on the PK of Combined Oral Contraceptives (COCs) in healthy female participants (Part B).

Phase:

PHASE1

Details

Lead Sponsor:

AstraZeneca

Collaborator:

Parexel

Treatments:

Itraconazole